WallStSmart
ITRM

Iterum Therapeutics PLC

NASDAQ: ITRM · HEALTHCARE · BIOTECHNOLOGY

$0.03
+0.00% today

Updated 2026-04-29

Market cap
$3.75M
P/E ratio
P/S ratio
9.62x
EPS (TTM)
$-0.72
Dividend yield
52W range
$0 – $1
Volume
32.7M

Iterum Therapeutics PLC (ITRM) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-13.6%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+100.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-10.3%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-21.6%
2025-11-13
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-12$0.00-100.0%$0.17$0.17+0.9%
2025-11-13$-0.20+4.8%$0.60$0.47-21.6%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$0.01$0.00-100.0%
2025-09-30$-0.21$-0.20+4.8%$390000.00
2025-06-30$-0.11$-0.16-45.5%
2025-03-31$-0.14$-0.14+0.0%
2024-12-31$-0.24$-0.12+50.0%
2024-09-30$-0.21$-0.24-14.3%
2024-06-30$-0.45$-0.30+33.3%
2024-03-31$-0.72$-0.46+36.1%
2023-12-31$-0.93$-0.94-1.1%$2.62M
2023-09-30$-0.91$-0.30+67.0%
2023-06-30$-0.79$-0.95-20.3%
2023-03-31$-1.18$-0.58+50.8%
2022-12-31$-1.15$-0.52+54.8%

Frequently asked questions

Has Iterum Therapeutics PLC beaten earnings estimates?
Iterum Therapeutics PLC has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -13.6% over the last 3 quarters.
How does ITRM stock react to earnings?
ITRM stock has moved an average of -10.3% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.